A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis

MLA

Frédéric Oberti, et al. “A Randomized Trial of 6-Month Norfloxacin Therapy in Patients with Child-Pugh Class C Cirrhosis.” Journal of Hepatology, vol. 66, Jan. 2017, p. S1. EBSCOhost, https://doi.org/10.1016/s0168-8278(17)30264-7.

APA

Frédéric Oberti, V. Di Martino, L. Elkrief, Rodolphe Anty, Didier Lebrec, Thierry Thevenot, Richard Moreau, Nathalie Gault, Jean-Marc Perarnau, Marie-Angèle Robic, Isabelle Ollivier-Hourmand, L. D’Alteroche, Pierre-Emmanuel Rautou, Blandine Pasquet, Alexandre Louvet, Violaine Ozenne, C. Bureau, Sophie Hillaire, Marika Rudler, … P. Nahon. (2017). A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis. Journal of Hepatology, 66, S1. https://doi.org/10.1016/s0168-8278(17)30264-7

Chicago

Frédéric Oberti, V. Di Martino, L. Elkrief, Rodolphe Anty, Didier Lebrec, Thierry Thevenot, Richard Moreau, et al. 2017. “A Randomized Trial of 6-Month Norfloxacin Therapy in Patients with Child-Pugh Class C Cirrhosis.” Journal of Hepatology 66 (January): S1. doi:10.1016/s0168-8278(17)30264-7.